Algen Biotechnologies Inc
San Francisco, CA · Biotech · Private
Machine learning platform for drug target discovery that analyzes single-cell RNA expression data from CRISPRi screens to identify transcriptional vulnerabilities in MYCN-driven cancers
- Grants
- $350K
- 1 award
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 19
- 3 granted · 16 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20212022
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · AlgenML: Drug target discovery platform for transcriptional reprogramming of MYCN-driven neuroblastoma | $350,000 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1593 | INSILICOS | — | — |
| 1594 | FAIRBANKS PHARMACEUTICALS | — | — |
| 1595 | Resonate Industries Inc | — | $555K |
| 1596 | Algen Biotechnologies Inc | — | — |
| 1597 | Novear Therapeutics LLC | — | — |
| 1598 | AVANT IMMUNOTHERAPEUTICS, INC. | — | — |
| 1599 | Reveal Pharmaceuticals, Inc. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Certain Chemical Compositions And Methods Of Use Thereofgranted
- Methods And Systems For Identifying Target Genesapplication
- Methods And Systems For Determining Drug Effectivenessapplication
- Methods And Systems For Identifying Target Genesgranted
- Certain Chemical Compositions And Methods Of Use Thereofgranted
- Methods And Systems For Identifying Target Genesapplication
- Compositions And Methods For Treating Ras-mutant Cancersapplication
- Methods And Systems For Determining Drug Effectivenessapplication
- Methods And Systems For Identifying Target Genesapplication
- Certain Chemical Compositions And Methods Of Use Thereofapplication
- Compositions And Methods For Treating Ras-mutant Cancersapplication
- Improved Methods And Compositions For Crispr Interference And Activationapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.